TMS therapy is FDA-cleared for OCD and has strong evidence for anxious depression — the most common presentation of depression in clinical practice. Research on generalized anxiety disorder is promising, though formal FDA clearance for GAD alone is still emerging. Dr. Mirza evaluates each patient individually to determine whether TMS is appropriate.
What TMS Is FDA-Cleared to Treat
It is important to start with what is established. TMS therapy currently holds FDA clearance for three indications:
- Major depressive disorder (MDD) — cleared since 2008, with the strongest evidence base
- Obsessive-compulsive disorder (OCD) — cleared by the FDA in 2018 using the BrainsWay Deep TMS system
- Smoking cessation — cleared in 2020 for nicotine dependence
Anxiety disorders — including generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and PTSD — are not yet FDA-cleared TMS indications as standalone diagnoses. However, this regulatory framing does not tell the complete clinical story. The relationship between TMS and anxiety is nuanced and important to understand.
At Hamilton Psychiatric Services in Hamilton, NJ, Dr. Mirza uses BrainsWay Deep TMS as part of comprehensive treatment plans for depression, OCD, and related conditions. Learn more about our TMS therapy program.
TMS for Anxious Depression: Strong Evidence
The most clinically relevant overlap between TMS and anxiety is anxious depression — major depressive disorder accompanied by significant anxiety symptoms. Research suggests that 50–70% of people with MDD also experience clinically meaningful anxiety. This subtype is extremely common in clinical practice.
Multiple clinical trials have specifically examined TMS outcomes in patients with anxious depression, and the results are encouraging:
- A landmark study published in the American Journal of Psychiatry found that TMS produced significant reductions in both depressive and anxiety symptoms in patients with anxious depression.
- The NeuroStar TMS clinical trial (the pivotal FDA trial for TMS) showed that TMS reduced anxiety scores on standardized rating scales alongside depression scores.
- Real-world registry data from thousands of patients confirm that anxiety symptoms — not just depressive symptoms — improve meaningfully during TMS treatment for MDD.
In practical terms, if your depression comes with significant worry, nervousness, or panic, TMS may address both dimensions of your condition simultaneously. This is one reason psychiatrists increasingly view TMS as relevant for patients with mixed depressive-anxiety presentations.
TMS for OCD: FDA-Cleared and Clinically Validated
OCD occupies a unique position in this discussion. While it is classified as an anxiety-related disorder and shares many features with anxiety disorders, it has its own FDA clearance for TMS — specifically using the BrainsWay Deep TMS system with its proprietary H7 coil, which targets the anterior cingulate cortex and medial prefrontal cortex involved in OCD circuitry.
Key facts about TMS for OCD:
- The FDA clearance was based on a randomized, sham-controlled multicenter trial demonstrating significant reduction in OCD symptoms (as measured by the Yale-Brown Obsessive Compulsive Scale) compared to placebo.
- The BrainsWay OCD protocol involves a brief symptom provocation step before stimulation — a clinician presents OCD-relevant stimuli to activate the relevant neural circuits just before the TMS pulses, enhancing treatment specificity.
- TMS for OCD is typically used alongside — not instead of — evidence-based psychotherapy for OCD (such as Exposure and Response Prevention, or ERP). The combination often produces better outcomes than either treatment alone.
If you or a loved one is struggling with OCD in New Jersey, this is an established, insurance-covered treatment option. Visit our anxiety disorders treatment page to learn more about how we approach OCD at Hamilton Psychiatric Services.
Research on TMS for Generalized Anxiety Disorder
The research on TMS for standalone generalized anxiety disorder is smaller in volume but consistently points in a positive direction. Several mechanisms suggest why TMS could be effective for GAD:
- The left dorsolateral prefrontal cortex (DLPFC) — the primary TMS target for depression — also plays a regulatory role in anxiety processing and emotional control.
- The right DLPFC, which is associated with fear processing and negative affect, has been targeted in some anxiety-focused TMS protocols using inhibitory stimulation (low-frequency TMS), with promising preliminary results.
- Small randomized trials and case series have shown reductions in GAD symptom scores following TMS, with some studies specifically noting improvements in worry severity and avoidance behavior.
It is honest to acknowledge that the evidence for GAD as an isolated diagnosis is not yet at the level required for FDA clearance. Larger randomized controlled trials are underway. But for patients with GAD who also have depression — an extremely common co-occurrence — TMS for the depressive component frequently produces collateral benefit for anxiety symptoms as well.
Who Might Benefit from TMS for Anxiety?
Dr. Mirza evaluates patients on an individual basis. Patients who may be strong candidates for TMS with an anxiety component include:
- Those with a primary diagnosis of MDD with significant anxious features or comorbid anxiety disorder
- Patients with OCD — especially those who have had partial response to medication or ERP therapy alone
- Patients with PTSD and comorbid depression — some preliminary evidence supports TMS for this combination
- Individuals who cannot tolerate SSRIs or SNRIs (the first-line medications for both depression and anxiety disorders) due to side effects
- Patients who prefer a non-medication approach or want to reduce their medication burden
Standalone generalized anxiety disorder without a depressive component is evaluated case by case. Dr. Mirza will discuss the evidence, your clinical profile, and expected insurance coverage honestly before making a recommendation.
Frequently Asked Questions: TMS and Anxiety
Is TMS covered by insurance for anxiety?
Insurance coverage for TMS is most reliably established for treatment-resistant MDD. Coverage for OCD is growing. For anxiety as a standalone diagnosis, coverage is less consistent. Our team verifies your specific benefits before treatment begins so there are no surprises.
Can TMS make anxiety worse?
Some patients experience a brief increase in anxiety in the early sessions of TMS — typically during the first one to two weeks — before improvement sets in. This is relatively uncommon and usually mild. It should be reported to Dr. Mirza, who can adjust the treatment approach if needed.
How does TMS for OCD differ from TMS for depression?
The coil placement, brain target, and protocol differ. OCD treatment uses the BrainsWay H7 coil targeting medial prefrontal and anterior cingulate circuits, and involves a symptom provocation step before each session. Depression treatment uses the H1 coil targeting the left DLPFC. Both are delivered at Hamilton Psychiatric using the BrainsWay system.
Does TMS replace therapy for anxiety?
No. TMS is a neurobiological treatment that works at the level of brain circuitry. Psychotherapy — particularly CBT for anxiety and ERP for OCD — addresses the cognitive and behavioral patterns that maintain anxiety. The combination of TMS and evidence-based therapy is often more powerful than either approach alone.
How long does it take to see anxiety relief from TMS?
Most patients who respond to TMS for depression or OCD begin noticing symptom changes within two to four weeks of starting treatment. Anxiety-related improvements often follow a similar timeline, sometimes with early gains in sleep and worry before broader mood improvements are felt.
Explore Whether TMS Is Right for Your Anxiety
Hamilton Psychiatric Services offers BrainsWay Deep TMS in Hamilton, NJ for depression, OCD, and related conditions. Dr. Mirza will conduct a comprehensive evaluation to determine whether TMS is clinically appropriate and likely to be covered by your insurance.
Call 609-631-7770 or schedule online to book a consultation. We serve patients throughout Hamilton, Trenton, and Mercer County, NJ, with telehealth available statewide.